Adiponectin, Leptin, and Chemerin in Elderly Patients with Type 2 Diabetes Mellitus: A Close Linkage with Obesity and Length of the Disease

Table 1

Sociodemographic, clinical, and analytical data for control group and patients with type 2 diabetes mellitus (T2DM).

	Control group; (𝑛=20)	T2DM patients; (𝑛=73)	𝑃 value
Gender (F/M)	12/8	37/36	0.399
Age (years)	60 ± 9	64 ± 10	0.127
Length of disease (years)	—	9 ± 7	—
Body mass index (kg/m^2)	26 ± 3	27 ± 4	0.304
Total cholesterol (mg/dL)	210 ± 48	196 ± 52	0.276
HDL cholesterol (mg/dL)	46 ± 18	40 ± 10	0.173
Triglycerides (mg/dL)	97 [64–184]	107 [78–155]	0.633
Adiponectin (μg/mL)	8.3 [6.8–14.2]	6.1 [4.5–7.9]	0.001
Leptin (ng/mL)	6.7 [4.6–14.7]	18.6 [7.1–46.6]	0.004
Male	4.9 [2.2–11.0]^a	7.4 [3.2–17.3]^b	0.216
Female	15.3 [6.7–25.2]	43.0 [20.8–59.3]	0.002
Chemerin (ng/mL)	89 [66–109]	179 [130–193]	<0.001

F: female; HDL: high-density lipoprotein; M: male.
^a𝑃: male versus female <0.01; ^b𝑃: male versus female <0.001.